European Journal of Clinical Microbiology

, Volume 4, Issue 1, pp 72–73 | Cite as

In vitro activity of five quinoline derivatives against nosocomial isolates ofStaphylococcus andPseudomonas species

  • F. D. Daschner
  • H. -M. Just


Internal Medicine Quinoline Vitro Activity Quinoline Derivative Nosocomial Isolate 


  1. 1.
    Shrire, L., Saunders, J., Traynor, R., Koornhof, H. J.; A laboratory assessment of ciprofloxacin and comparable antimicrobial agents. European Journal of Clinical Microbiology 1984, 3: 328–332.PubMedGoogle Scholar
  2. 2.
    Hoogkamp-Korstanje, J. A. A.: Comparative in vitro activity of five quinolone derivatives and five other antimicrobial agents used in oral therapy. European Journal of Clinical Microbiology 1984, 3: 333–338.PubMedGoogle Scholar
  3. 3.
    Wise, R., Andrews, J. M., Edwards, L. J.: In vitro activity of Bay 09867, a new quinoline derivative, compared with that of other antimicrobial agents. Antimicrobial Agents and Chemotherapy 1983, 23: 559–564.PubMedGoogle Scholar
  4. 4.
    Bauernfeind, A., Petermüller, C.: In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid. European Journal of Clinical Microbiology 1983, 2: 111–115.PubMedGoogle Scholar

Copyright information

© Vieweg Publishing 1985

Authors and Affiliations

  • F. D. Daschner
    • 1
  • H. -M. Just
    • 1
  1. 1.Department of Hospital EpidemiologyUniversity HospitalFreiburgFRG

Personalised recommendations